Astellas Pharma Inc. (TYO:4503)
Japan flag Japan · Delayed Price · Currency is JPY
1,580.50
+24.00 (1.54%)
Aug 5, 2025, 3:30 PM JST

Astellas Pharma Revenue

Astellas Pharma had revenue of 505.79B JPY in the quarter ending June 30, 2025, with 6.91% growth. This brings the company's revenue in the last twelve months to 1.94T, up 14.29% year-over-year. In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T with 19.25% growth.

Revenue (ttm)
1,944.99B
Revenue Growth
+14.29%
P/S Ratio
1.45
Revenue / Employee
142.56M
Employees
13,643
Market Cap
2,829.59B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251,912.32B308.65B19.25%
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 20211,249.53B-51.32B-3.94%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.22B
Daiichi Sankyo Company1,924.68B
Takeda Pharmaceutical Company4,480.25B
HOYA Corporation876.09B
Otsuka Holdings2,393.18B
Terumo1,036.17B
Shionogi &440.50B
Olympus997.33B
Revenue Rankings